Substituted pyrazoles suitable as p38 kinase inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142355, 5142372, 514255, 514318, 514341, 546193, 546194, 546211, 5462754, C07D40104, C07D40304, C07D41304, A61K 3144, A61K 31445, A61K 315377

Patent

active

060874961

ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I: ##STR1## wherein R.sup.1, R.sup.2, Ar.sup.1 and HetAr.sup.2 are as described in the specification.

REFERENCES:
patent: 3254093 (1966-05-01), Huisgen et al.
patent: 3984431 (1976-10-01), Gueremy et al.
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5051518 (1991-09-01), Murray et al.
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5559137 (1996-09-01), Adams et al.
patent: 5589439 (1996-12-01), Goto et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
Sep. 25, 1998 PCT International Search Report (PCT/US98/10807.
Moerck et al, J. Chem. Soc., Chem. Commun. No. 19, 1974, pp. 782-783.
DannHardt et al, Arch. Pharm., vol. 321, No. 1, 1988, pp. 17-19.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted pyrazoles suitable as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazoles suitable as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles suitable as p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-543479

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.